Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Follow-Up Questions
Carlsmed Inc의 CEO는 누구입니까?
Mr. Michael Cordonnier은 2018부터 회사에 합류한 Carlsmed Inc의 Chairman of the Board입니다.
CARL 주식의 가격 성능은 어떻습니까?
CARL의 현재 가격은 $12.49이며, 전 거래일에 increased 1.09% 하였습니다.
Carlsmed Inc의 주요 사업 주제나 업종은 무엇입니까?
Carlsmed Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Carlsmed Inc의 시가총액은 얼마입니까?
Carlsmed Inc의 현재 시가총액은 $332.1M입니다
Carlsmed Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 7명의 분석가가 Carlsmed Inc에 대한 분석 평가를 실시했으며, 이는 4명의 강력한 매수, 6명의 매수, 1명의 보유, 0명의 매도, 그리고 4명의 강력한 매도를 포함합니다
